Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | AKT1 | P31749 | 2/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | CDC25A | P30304 | 1/20 | 0.52 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.44 |
| ▸ | PTAFR | P25105 | 1/20 | 0.44 |
| ▸ | HTR1D | P28221 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15393208 | 1.00 | LMNA (0.52) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL1260913 | 1.00 | LMNA (0.52) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL15393394 | 1.00 | LMNA (0.52) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL1260055 | 0.99 | AKT1 (0.50) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL1260696 | 0.97 | AKT1 (0.49) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL1260678 | 0.97 | LMNA (0.52) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL15393527 | 0.97 | LMNA (0.52) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL15393520 | 0.97 | LMNA (0.52) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL1260704 | 0.97 | LMNA (0.52) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL1261300 | 0.96 | AKT1 (0.50) | LMNAAKT1ESR1ADORA3CDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240189121-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2024-06-13 | — | — | US | claimed |
| EP-3666299-B1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP (US) | 2024-05-15 | — | — | EP | claimed |
| US-11903850-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2024-02-20 | — | — | US | claimed |
| US-20230036800-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2023-02-02 | — | — | US | claimed |
| US-11406514-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2022-08-09 | — | — | US | claimed |
| US-11369497-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2022-06-28 | — | — | US | claimed |
| US-20210068991-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2021-03-11 | — | — | US | claimed |
| US-10835393-B2 | Anti-thrombogenic medical devices and methods | COVIDIEN LP (US) | 2020-11-17 | — | — | US | claimed |
| EP-3666299-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | Covidien LP (US) | 2020-06-17 | — | — | EP | claimed |
| EP-3400973-B1 | METHOD OF MANUFACTURING ANTI-THROMBOGENIC MEDICAL DEVICES | COVIDIEN LP (US) | 2020-02-12 | — | — | EP | claimed |
| WO-2015077081-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP (US) | 2015-05-28 | — | — | WO | claimed |
| US-20150148882-A1 | ANTI-THROMBOGENIC MEDICAL DEVICES AND METHODS | COVIDIEN LP | 2015-05-28 | — | — | US | claimed |
| EP-2875833-A1 | Anti-thrombogenic medical devices and methods | Covidien LP (US) | 2015-05-27 | — | — | EP | claimed |
| US-20150140344-A1 | COATED MEDICAL DEVICES | COVIDIEN LP | 2015-05-21 | — | — | US | claimed |
| EP-2801401-A1 | OUTSTANDINGLY CONTAMINATION RESISTANT REVERSE OSMOSIS MEMBRANE AND PRODUCTION METHOD THEREFOR | LG Chem, Ltd. (KR) | 2014-11-12 | — | — | EP | claimed |
| US-8646617-B2 | Reverse osmosis membrane having good antifouling properties and method of manufacturing the same | LG CHEM, LTD. (KR) | 2014-02-11 | — | — | US | claimed |
| US-20130306550-A1 | REVERSE OSMOSIS MEMBRANE HAVING GOOD ANTIFOULING PROPERTIES AND METHOD OF MANUFACTURING THE SAME | LG CHEM, LTD. (KR) | 2013-11-21 | — | — | US | claimed |
| US-20100094339-A1 | COATING COMPOSITIONS | COVIDIEN LP | 2010-04-15 | — | — | US | claimed |
| EP-2120824-A1 | COATING COMPOSITIONS | Tyco Healthcare Group LP (US) | 2009-11-25 | — | — | EP | claimed |
| WO-2008143654-A1 | COATING COMPOSITIONS | TYCO HEALTHCARE GROUP LP (US) | 2008-11-27 | — | — | WO | claimed |